Plus Therapeutics Inc (NASDAQ: PSTV) is -53.90% lower on its value in year-to-date trading and has touched a low of $0.24 and a high of $2.67 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PSTV stock was last observed hovering at around $0.70 in the last trading session, with the day’s loss setting it -0.17%.
Currently trading at $0.53, the stock is -23.38% and -38.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.69 million and changing -24.05% at the moment leaves the stock -55.85% off its SMA200. PSTV registered -75.46% loss for a year compared to 6-month loss of -56.90%.
The stock witnessed a -17.11% gain in the last 1 month and extending the period to 3 months gives it a -52.67%, and is -5.94% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.98% over the week and 19.24% over the month.
Plus Therapeutics Inc (PSTV) has around 21 employees, a market worth around $9.01M and $5.82M in sales. Profit margin for the company is -222.84%. Distance from 52-week low is 120.87% and -80.15% from its 52-week high.
with sales reaching $1.11M over the same period.The EPS is expected to grow by 57.69% this year, but quarterly earnings will post -16.51% year-over-year. Quarterly sales are estimated to shrink -33.66% in year-over-year returns.
The shares outstanding are 17.00M, and float is at 16.57M with Short Float at 12.57%.
Plus Therapeutics Inc (PSTV) Insider Activity
Plus Therapeutics Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Hawkins Richard J (Director) bought a total of 4,000 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $1.50 per share for $5996.0. Following the transaction, the insider now directly holds 15188.0 shares of the PSTV stock.
Still, SEC filings show that on Sep 12 ’24, Hawkins Richard J (Director) acquired 6,285 shares at an average price of $1.35 for $8512.0. The insider now directly holds 11,188 shares of Plus Therapeutics Inc (PSTV).
